| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ITCH_0003100 | Intron-Exon-Intron | chr20:32980327-33012331 | chr20:34392521-34424525 | 46 nt | 0.4565 |
| hsa_ITCH_0002900 | Intron-Exon-Intron | chr20:32980327-33030108 | chr20:34392521-34442303 | 2379 nt | 0.4300 |
| hsa_ITCH_0003200 | Intron-Exon-Intron | chr20:32980373-32996598 | chr20:34392567-34408792 | 1457 nt | 0.4207 |
| hsa_ITCH_0003300 | Intron-Exon-Intron | chr20:32980373-33014060 | chr20:34392567-34426254 | 102 nt | 0.3529 |
| hsa_ITCH_0003500 | Intron-Exon-Intron | chr20:32980539-32981687 | chr20:34392733-34393881 | 1149 nt | 0.4386 |
| hsa_ITCH_0003600 | Intron-Exon-Intron | chr20:32980539-33001685 | chr20:34392733-34413879 | 1554 nt | 0.4260 |
| hsa_ITCH_0003400 | Intron-Exon-Intron | chr20:32980539-33045279 | chr20:34392733-34457474 | 2497 nt | 0.4445 |
| hsa_ITCH_0004200 | Intron-Exon-Intron | chr20:32980543-32981687 | chr20:34392737-34393881 | 1145 nt | 0.4384 |
| hsa_ITCH_0004300 | Intron-Exon-Intron | chr20:32980543-32996598 | chr20:34392737-34408792 | 1287 nt | 0.4351 |
| hsa_ITCH_0003700 | Intron-Exon-Intron | chr20:32980543-33030108 | chr20:34392737-34442303 | 2163 nt | 0.4438 |
A review consolidating research in humans and model organisms indicates that the circITCH functions as a tumor suppressor in glioma by sponging miR-214 to allow expression of ubiquitin-protein ligase E3, thereby suppressing proliferation and preventing apoptosis, while also targeting the Wnt/β-catenin pathway [Mehta et al. DOI:10.1016/j.pneurobio.2020.101746]. In oesophageal squamous cell carcinoma, the circITCH is downregulated and increases ITCH expression to inhibit the Wnt/β-catenin pathway [Lee et al. DOI:10.1016/j.biopha.2018.12.052]. circITCH hsa_circ_0001141 (circITCH) was found to be lower in the hearts of cancer patients suffering from doxorubicin-induced cardiomyopathy compared to those with dilated cardiomyopathy, hypertrophic cardiomyopathy, and healthy donors, and its expression ameliorates doxorubicin-induced cardiomyocyte injury [Tian et al. DOI:10.3390/molecules26041155].